Laser plus strengthening for thin, at-risk corneas
Part of Eyes & vision clinical trials.
This trial tests a combined treatment for people with thin, suspicious corneas that may be at risk of developing keratoconus. The treatment uses a laser to correct vision and a special cross-linking step to strengthen the cornea and prevent future progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cornea (the clear front part of your eye) is thin — less than 490 microns thick.
- Your cornea is steeper than average, or has an irregular shape.
- You have at least 1.5 diopters of astigmatism (which causes blurred vision).
- Special measurements from a corneal mapping machine show signs that your cornea might be at risk for weakening (like early keratoconus).
- You haven't been diagnosed with full-blown keratoconus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a procedure called PXL‑Platinum 330 can safely and effectively strengthen corneas that are thinning (such as keratoconus or related conditions). It aims to see if the treatment can help stabilize or improve the cornea’s shape while keeping side effects low.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This Phase 2 study tests how safe and well a corneal cross-linking device (called PXL-Platinum 330) works for people with corneal ectasia (a thinning/steepening of the cornea). If you qualify, the goal is to help stop or slow further worsening of your cornea shape and improve eye stability.
This study tests whether a special “Brillouin” microscope scan can spot corneal ectasia and related cornea conditions. It may help doctors diagnose problems earlier and better sort out who needs closer eye care.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
Hear when a new Thin Suspicious Cornea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.